《B 中国高血压防治指南2016 指南导读》.pdf

42 ●指南导读● 《中国医学前沿杂志 （电子版）》2011年第3卷第5期 中国高血压防治指南2010 中国高血压防治指南修订委员会 2010 Chinese guidelines for the management of hypertension Writing Group of 2010 Chinese Guidelines for the Management of Hypertension Corresponding author: LIU Li-sheng, Email: llschl@ Abstract The 2010 Chinese guidelines for the management of hypertension is an update of the 【 】 previous versions in 2005 and 1999. A guideline committee of nearly 100 members appointed by the Chinese Hypertension League (CHL) and the National Centre for Cardiovascular Disease (NCCD), in collaboration with the Chinese societies of cardiology, nephrology, neurology, gynecology and endocrinology, convened on several occasions and discussed the guidelines, drafted by a core writing group. The prevalence of hypertension has been increasing in China for decades, and reached 18.8% in the year 2002. The rates of awareness, treatment and control for hypertension patients remain low compared to high income countries, in spite of substantial improvements since 1991. In some communities, the control rate of hypertension increased up to 60%, The mortality rate of stroke, which is the major complication of hypertension in the Chinese population, gradually decreased during the period, more so in urban areas than in rural areas for the middle-aged and elderly populations; in the younger age groups, however, it increased. As hypertension is a “cardiovascular syndrome”, the management strategy should be based on the overall risk of cardiovascular disease estimated with all related risk factors, target organ damage and co-morbidity of patients. The target blood pressure is set at SBP/DBP140/90 mm Hg (1 mm Hg=0.133 kPa) in uncomplicated hypertension; 150/90 mm Hg for the elderly ( ≥65 years) or, if tolerable, 140/90 mm Hg; and130/80 mm Hg for those with diabetes, coronary heart disease or renal disease. For these high risk patients, the manage